Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
9.55
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
9.20
-0.35 (-3.66%)
Pre-market: Sep 8, 2026, 6:17 AM EDT

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $56.50M in the quarter ending June 30, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $231.24M, down -2.86% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%.

Revenue (ttm)
$231.24M
Revenue Growth
-2.86%
P/S Ratio
2.13
Revenue / Employee
$1,291,866
Employees
179
Market Cap
492.97M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ginkgo Bioworks Holdings132.42M
Prothena Corporation54.53M
Editas Medicine47.01M
C4 Therapeutics35.04M
Ocugen4.58M
Entera Bio42.00K
Revenue Rankings

PBYI News

More News